InsidersTradesSigma
Follow the Accustem Sciences Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Accustem Sciences Inc. has logged 13 public disclosures. Market capitalisation: €3.3m. The latest transaction was reported on 16 June 2025 (Acquisition). Among the most active insiders: CERRONE GABRIELE M. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
€199,523
13 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2025
Declarations13 total
2,000 shares@ US$1.000.9% of flowCommon StockSEC:0001641172-25-015197:0
Canonical exit: 11 Sept 2025 (T+90)
28,205 shares@ US$0.394.8% of flowCommon StockSEC:0001641172-25-015003:0
Canonical exit: 9 Sept 2025 (T+90)
35,000 shares@ US$0.66511.3% of flowCommon StockSEC:0001641172-25-003618:0
Canonical exit: 7 Jul 2025 (T+90)
35,000 shares@ US$0.6511.1% of flowCommon StockSEC:0001641172-25-003222:2
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.44721.7% of flowCommon StockSEC:0001641172-25-003222:0
Canonical exit: 16 Jun 2025 (T+90)
17,802 shares@ US$0.6095.3% of flowCommon StockSEC:0001641172-25-003222:1
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.38119.5% of flowCommon StockSEC:0001493152-25-000211:0
Canonical exit: 31 Mar 2025 (T+90)
5,000 shares@ US$1.403.5% of flowCommon StockSEC:0001493152-23-000064:0
Canonical exit: 30 Mar 2023 (T+90)
3,729 shares@ US$1.422.7% of flowCommon StockSEC:0001493152-22-034396:0
Canonical exit: 2 Mar 2023 (T+90)
24,500 shares@ US$1.0513.2% of flowCommon StockSEC:0001493152-22-033239:0
Canonical exit: 16 Feb 2023 (T+90)
10,000 shares@ US$0.794.1% of flowCommon StockSEC:0001493152-22-020942:0
Canonical exit: 30 Oct 2022 (T+90)
20,000 shares@ US$0.500.18% mcap63.9% of flowCommon StockSEC:0001493152-22-016256:0
Canonical exit: 6 Sept 2022 (T+90)
4,181 shares@ US$1.350.10% mcap36.1% of flowCommon StockSEC:0001493152-22-011318:0
Canonical exit: 24 Jul 2022 (T+90)
13 of 13 declarations
关于 Accustem Sciences Inc.
Accustem Sciences Inc. 是一家专注于开发癌症诊断解决方案的公司。它旨在改进肿瘤疾病的检测和监测方法。